» Articles » PMID: 14974030

Thrombolysis for Cerebral Vein and Dural Sinus Thrombosis

Overview
Publisher Wiley
Date 2004 Feb 20
PMID 14974030
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Treatment of cerebral sinus thrombosis with thrombolytics has been reported in cases with a deteriorating clinical course despite anticoagulant therapy. The rationale of this treatment is to promote rapid recanalisation of the occluded sinus.

Objectives: To review the available evidence on the efficacy and safety of thrombolysis in confirmed cerebral sinus thrombosis.

Search Strategy: We searched the Cochrane Stroke Group trials register (March 2003), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2003), MEDLINE (1966 to March 2003), EMBASE (1980 to March 2003), and reference lists of all relevant publications.

Selection Criteria: We aimed to analyse separately unconfounded randomised controlled trials comparing thrombolytic agent with placebo, or thrombolytic agent with antithrombotic therapy, or thrombolytic agent and antithrombotic with antithrombotic alone, in patients with dural sinus thrombosis (confirmed by MR venography, intra-arterial venography or CT venography).

Data Collection And Analysis: Two groups of reviewers independently applied the inclusion criteria.

Main Results: No randomised controlled trials were found.

Reviewer's Conclusions: There is currently no available evidence from randomised controlled trials regarding the efficacy or safety of thrombolytic therapy in dural sinus thrombosis. A randomised controlled trial is justified to test this therapy especially in patients predicted to have a poor prognosis.

Citing Articles

Endovascular thrombectomy for severe cerebral venous thrombosis: A comprehensive meta-analysis assessing safety and efficacy.

Ghozy S, Orscelik A, Tolba H, Abdelghaffar M, Kobeissi H, Ghaith H Interv Neuroradiol. 2024; :15910199241285071.

PMID: 39344306 PMC: 11559896. DOI: 10.1177/15910199241285071.


A Puzzling Diagnosis of Cerebral Vein Thrombosis in a COVID-19-Vaccinated Patient.

Alsallamin I, Somoza-Cano F, Zakarna L, Aggarwal P, Karia R, Bawwab A Cureus. 2022; 14(6):e25860.

PMID: 35836469 PMC: 9273173. DOI: 10.7759/cureus.25860.


Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.

Coutinho J, Zuurbier S, Bousser M, Ji X, Canhao P, Roos Y JAMA Neurol. 2020; 77(8):966-973.

PMID: 32421159 PMC: 7235912. DOI: 10.1001/jamaneurol.2020.1022.


Endovascular suction thrombectomy for severe cerebral venous sinus thrombosis: A report of two cases.

Najjar A, Rasheedi J, Kurdi K, Hasan A, Almekhlafi M, Baeesa S J Taibah Univ Med Sci. 2019; 13(1):87-92.

PMID: 31435308 PMC: 6694903. DOI: 10.1016/j.jtumed.2017.06.004.


Prolonged Microcatheter-Based Local Thrombolytic Infusion as a Salvage Treatment After Failed Endovascular Treatment for Cerebral Venous Thrombosis: A Multicenter Experience.

Qureshi A, Grigoryan M, Saleem M, Aytac E, Wallery S, Rodriguez G Neurocrit Care. 2018; 29(1):54-61.

PMID: 29484582 DOI: 10.1007/s12028-018-0502-3.


References
1.
Persson L, Lilja A . Extensive dural sinus thrombosis treated by surgical removal and local streptokinase infusion. Neurosurgery. 1990; 26(1):117-21. DOI: 10.1097/00006123-199001000-00016. View

2.
Smith A, Cornblath W, Deveikis J . Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology. 1997; 48(6):1613-9. DOI: 10.1212/wnl.48.6.1613. View

3.
Barnwell S, Higashida R, Halbach V, Dowd C, Hieshima G . Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery. 1991; 28(1):135-42. DOI: 10.1097/00006123-199101000-00019. View

4.
Holder C, Bell D, Lundell A, Ulmer J, Glazier S . Isolated straight sinus and deep cerebral venous thrombosis: successful treatment with local infusion of urokinase. Case report. J Neurosurg. 1997; 86(4):704-7. DOI: 10.3171/jns.1997.86.4.0704. View

5.
Benamer H, Bone I . Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?. J Neurol Neurosurg Psychiatry. 2000; 69(4):427-30. PMC: 1737135. DOI: 10.1136/jnnp.69.4.427. View